Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jun 11, 2007 at 8:29 AM EDT

Alzheimer’s Data Pumps Medivation & Neurochem (MDVN, NRMX)

Some new data is helping two small biotech stocks today at the Alzheimer’s Association International Conference on Prevention of Dementia…

Douglas A. McIntyre | Jun 8, 2007 at 8:02 AM EDT

Can A Genentech Upgrade Fix Its Woes? (DNA)

This morning shares of Genentech (DNA-NYSE) are trading up 1.3% at just under $76.00 after a Deutsche Bank upgrade on…

Douglas A. McIntyre | Jun 6, 2007 at 2:11 PM EDT

Dendreon’s $75 Million Borrowing, Almost For Free (DNDN)

Dendreon (DNDN-NASDAQ) announced this morning that it did price its $75 million in convertible senior subordinated notes due 2014 via…

Douglas A. McIntyre | Jun 5, 2007 at 6:32 PM EDT

Cramer Backs Acadia Pharmaceuticals (ACAD)

Cramer has a speculative little drug stock that keeps getting thrown to him in the Lightning Round: Acadia Pharmaceuticals (ACAD). …

Douglas A. McIntyre | Jun 4, 2007 at 10:08 PM EDT

Amgen Buys Ilypsa, Diversification Via Acquisition

Amgen (AMGN) is paying a hefty sum to diversify its Aranesp and Epogen franchises. The company is acquiring developmental-stage Ilypsa,…

Douglas A. McIntyre | Jun 4, 2007 at 6:35 AM EDT

Dendreon Taps Financing Sooner Than Expected

Shares of Dendreon (DNDN) are trading down some 7% pre-market after the company announced that it was going to offer…

Douglas A. McIntyre | Jun 1, 2007 at 9:05 AM EDT

Dendreon Kicked By Banc of America

Banc of America has noted that yesterday’s ‘positive data’ is actually not new and that the interim data will not…

Douglas A. McIntyre | May 31, 2007 at 8:40 AM EDT

Dendreon Catches a Break From The FDA

Dendreon (DNDN-NASDAQ) is benefitting from something that become thought of as a low probability event: an FDA that buckled at…

Douglas A. McIntyre | May 30, 2007 at 6:30 PM EDT

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. …

Douglas A. McIntyre | May 30, 2007 at 9:23 AM EDT

Novacea and Schering-Plough Prostate Cancer Pact; Remind You of Anyone?

Novacea (NOVC-NASDAQ) is seeing its shares up more than 70% after signing a pact with Schering-Plough (SGP-NYSE) over the development…

Douglas A. McIntyre | May 30, 2007 at 7:30 AM EDT

Biogen Idec Leverages Up For $3 Billion Share Buyback Plan (BIIB)

Biogen Idec inc. (BIIB-NASDAQ) is trading up roughly 4% pre-market at $51.40, within striking distance of its $52.72 high over…

Douglas A. McIntyre | May 29, 2007 at 7:12 PM EDT

Dendreon Volume and Volatility Compress Ahead of ASCO (DNDN)

If you thought the day would never come that Dendreon (DNDN-NASDAQ) would see its volatility, its hyperactive volume, and its…

Douglas A. McIntyre | May 29, 2007 at 11:39 AM EDT

Cramer’s Three Biotech Picks, And His Biotech Strategy

Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDN Jim Cramer has a video on TheStreet.com "Wall St. Confidential"…

Douglas A. McIntyre | May 25, 2007 at 7:24 AM EDT

Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)

Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD The short interest is on the rise overall,…

Douglas A. McIntyre | May 24, 2007 at 3:01 PM EDT

Northfield Laboratories Turns Into a Zombie (NFLD)

Northfield Laboratories Inc. (NFLD-NASDAQ) has probably just joined the ranks of the biotech zombies after the drop witnessed yesterday and…

1 … 368 369 370 371 372 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Alzheimer’s Data Pumps Medivation & Neurochem (MDVN, NRMX)

Can A Genentech Upgrade Fix Its Woes? (DNA)

Dendreon’s $75 Million Borrowing, Almost For Free (DNDN)

Cramer Backs Acadia Pharmaceuticals (ACAD)

Amgen Buys Ilypsa, Diversification Via Acquisition

Dendreon Taps Financing Sooner Than Expected

Dendreon Kicked By Banc of America

Dendreon Catches a Break From The FDA

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Novacea and Schering-Plough Prostate Cancer Pact; Remind You of Anyone?

Biogen Idec Leverages Up For $3 Billion Share Buyback Plan (BIIB)

Dendreon Volume and Volatility Compress Ahead of ASCO (DNDN)

Cramer’s Three Biotech Picks, And His Biotech Strategy

Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)

Northfield Laboratories Turns Into a Zombie (NFLD)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

Alzheimer’s Data Pumps Medivation & Neurochem (MDVN, NRMX)

Can A Genentech Upgrade Fix Its Woes? (DNA)

Dendreon’s $75 Million Borrowing, Almost For Free (DNDN)

Cramer Backs Acadia Pharmaceuticals (ACAD)

Amgen Buys Ilypsa, Diversification Via Acquisition

Dendreon Taps Financing Sooner Than Expected

Dendreon Kicked By Banc of America

Dendreon Catches a Break From The FDA

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Novacea and Schering-Plough Prostate Cancer Pact; Remind You of Anyone?

Biogen Idec Leverages Up For $3 Billion Share Buyback Plan (BIIB)

Dendreon Volume and Volatility Compress Ahead of ASCO (DNDN)

Cramer’s Three Biotech Picks, And His Biotech Strategy

Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)

Northfield Laboratories Turns Into a Zombie (NFLD)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%